Lunai Bioworks (LNAI) revenue and earnings history
Lunai Bioworks reported revenue of $52K for fiscal 2026 (year ended Jun 30, 2026), and net income of −$3.56M.
Revenue and net income, 15 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026ended Jun 30, 2026 | $52K | −$8.7M | −$3.56M | −$5.29M | $1.2K | −$5.29M | $630K | — | — | $1.71M | — | 10-K |
| 2025ended Jun 30, 2025 | — |
The latest quarter, insider trades and fund moves: Lunai Bioworks (LNAI) on OQRO.
Common questions
What was Lunai Bioworks's revenue in fiscal 2026?
$52K for the year ended Jun 30, 2026, as reported in its 10-K filed Oct 13, 2026.
Has Lunai Bioworks been profitable?
It reported a net loss in 13 of the years shown (2013, 2014, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025, 2026). The highest net income was −$1.74M in fiscal 2016.
What was Lunai Bioworks's free cash flow in fiscal 2026?
−$5.29M: operating cash flow of −$5.29M minus capital expenditure of $1.2K. OQRO calculates free cash flow this way from the two filed lines.
Where these figures come from
The SEC’s companyfacts data: every figure Lunai Bioworks tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.